M. Téllez

J. Picazo, F. J. Candel, A. Valdivia, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy.

M. Serrano-Ríos, M. T. Larrad, V. Estrada, 2002 .

Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant

J. Losa, J. Bisbe, S. Reus, 2018, Open forum infectious diseases.

Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis

Cifuentes, Fariñas, Reus, 2018 .

Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics

M. Crespo, A. Rivero, M. Vivancos, 2016, Open forum infectious diseases.

Sexualized Drug Use (Chemsex) Is Associated with High‐Risk Sexual Behaviors and Sexually Transmitted Infections in HIV‐Positive Men Who Have Sex with Men: Data from the U‐SEX GESIDA 9416 Study

J. Troya, P. Ryan, J. Casado, 2018, AIDS patient care and STDs.

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry

C. Macaya, A. Fernández-Ortiz, A. Bardají, 2020, Internal and Emergency Medicine.

High efficacy of Resistance-guided retreatment of HCVpatients failing NS5A inhibitors in real world.

J. Crespo, J. Pascasio, J. Salmerón, 2019, Journal of hepatology.

Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids

V. Soriano, J. González-lahoz, I. Jiménez-Nácher, 2000, AIDS.

Effect of An Induction Period of Pegylated Interferon-α2A and Ribavirin on Early Virological Response in HIV–HCV-Coinfected Patients: Results from the Coral-2 Study

R. Paredes, B. Clotet, C. Tural, 2011, Antiviral therapy.

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

B. Clotet, M. Odriozola, J. Olalla, 2017, The Journal of antimicrobial chemotherapy.

Prognosis of AIDS-Related Systemic Non-Hodgkin Lymphoma Treated With Chemotherapy and Highly Active Antiretroviral Therapy Depends Exclusively on Tumor-Related Factors

J. Ribera, Jesús Santos, J. Berenguer, 2007, Journal of acquired immune deficiency syndromes.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

I. Martínez, M. Salavert, E. Ribera, 2019, Scientific Reports.

HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1

J. Losa, J. Calleja, C. Fernández-Rodríguez, 2019, Open forum infectious diseases.

Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019

J. Losa, J. Navarro, L. Force, 2022, HIV medicine.

Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals.

J. Losa, J. Troya, J. Berenguer, 2019, AIDS.

Comparison of CHOP treatment with specific short-intensive chemotherapy in AIDS-related Burkitt's lymphoma or leukemia.

J. Esteve, A. Oriol, S. Brunet, 2011, Medicina clinica.

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DU

D. Podzamczer, B. Clotet, E. Negredo, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C.

J. Benito, V. Soriano, J. Pineda, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

Dao Sen Wang, M. Poljak, F. Ceccherini‐Silberstein, 2022, JHEP reports : innovation in hepatology.

Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).

D. Podzamczer, B. Clotet, J. Gatell, 2015, Enfermedades Infecciosas y Microbiologia Clinica.

Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.

C. Tural, J. Mallolas, M. Crespo, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-α for the treatment of chronic hepatitis C in HIV-infected patients: the PERICO trial.

V. Soriano, J. Pineda, A. Terrón, 2012, The Journal of infectious diseases.

Effects of Sustained Viral Response in Patients With HIV and Chronic Hepatitis C and Nonadvanced Liver Fibrosis

M. Crespo, C. Quereda, J. Bellón, 2014, Journal of acquired immune deficiency syndromes.

Leptin and Adipose Tissue Maldistribution in HIV‐Infected Male Patients With Predominant Fat Loss Treated With Antiretroviral Therapy

M. Serrano-Ríos, M. T. Larrad, V. Estrada, 2002, Journal of acquired immune deficiency syndromes.

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial

J. De La Torre, J. Prada, S. Reus, 2018, The Journal of antimicrobial chemotherapy.

Effects of eradication of HCV on cardiovascular risk and preclinical atherosclerosis in HIV/HCV-coinfected patients.

J. Bermejo, J. Navarro, C. Quereda, 2020, Journal of acquired immune deficiency syndromes.

Transmission of HIV type 1 through blood transfusion from an antibody-negative/p24 antigen-negative donor.

B. Rodés, C. Toro, E. Poveda, 2003, AIDS research and human retroviruses.